+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

G-CSF Biosimilar Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 117 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5940467
Description Jump to:

Quick Summary:

In an ever-evolving pharmaceutical landscape, understanding the global market for G-CSF Biosimilars is vital for stakeholders committed to making informed, strategic decisions. As biosimilars pave the way for a new era in treatment affordability and accessibility, our comprehensive market research report presents an in-depth analysis of industry trends, regional nuances, and competitive dynamics.

Our meticulously crafted report is tailored for senior business executives, providing a granular view of supply and demand metrics, pricing strategies, and the market forces shaping the G-CSF Biosimilar landscape across key regions and countries. It goes beyond the numbers to deliver a strategic competitor analysis, complete with company profiles, SWOT analyses, and insights into market shares, all framed to guide effective decision-making and investment strategies. With this report, executives will have the necessary intelligence to stay ahead in the competitive pharmaceutical arena.

This report describes the global market size of G-CSF Biosimilar from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Blood Disorders
  • Oncology Diseases
  • Chronic And Autoimmune Diseases
  • Growth Hormone Deficiencies

Companies Covered:

  • Pfizer
  • Novartis
  • Roche
  • Merck & Co.Sanofi
  • Johnson & Johnson
  • Gilead Science
  • GlaxoSmithKline
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 G-Csf Biosimilar Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast G-Csf Biosimilar Market in North America (2019-2029)
8.1 G-Csf Biosimilar Market Size
8.2 G-Csf Biosimilar Market by End Use
8.3 Competition by Players/Suppliers
8.4 G-Csf Biosimilar Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast G-Csf Biosimilar Market in South America (2019-2029)
9.1 G-Csf Biosimilar Market Size
9.2 G-Csf Biosimilar Market by End Use
9.3 Competition by Players/Suppliers
9.4 G-Csf Biosimilar Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast G-Csf Biosimilar Market in Asia & Pacific (2019-2029)
10.1 G-Csf Biosimilar Market Size
10.2 G-Csf Biosimilar Market by End Use
10.3 Competition by Players/Suppliers
10.4 G-Csf Biosimilar Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast G-Csf Biosimilar Market in Europe (2019-2029)
11.1 G-Csf Biosimilar Market Size
11.2 G-Csf Biosimilar Market by End Use
11.3 Competition by Players/Suppliers
11.4 G-Csf Biosimilar Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast G-Csf Biosimilar Market in MEA (2019-2029)
12.1 G-Csf Biosimilar Market Size
12.2 G-Csf Biosimilar Market by End Use
12.3 Competition by Players/Suppliers
12.4 G-Csf Biosimilar Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global G-Csf Biosimilar Market (2019-2024)
13.1 G-Csf Biosimilar Market Size
13.2 G-Csf Biosimilar Market by End Use
13.3 Competition by Players/Suppliers
13.4 G-Csf Biosimilar Market Size by Type
Chapter 14 Global G-Csf Biosimilar Market Forecast (2024-2029)
14.1 G-Csf Biosimilar Market Size Forecast
14.2 G-Csf Biosimilar Application Forecast
14.3 Competition by Players/Suppliers
14.4 G-Csf Biosimilar Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and G-CSF Biosimilar Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.2 Novartis
15.2.1 Company Profile
15.2.2 Main Business and G-CSF Biosimilar Information
15.2.3 SWOT Analysis of Novartis
15.2.4 Novartis G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.3 Roche
15.3.1 Company Profile
15.3.2 Main Business and G-CSF Biosimilar Information
15.3.3 SWOT Analysis of Roche
15.3.4 Roche G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.4 Merck & Co.Sanofi
15.4.1 Company Profile
15.4.2 Main Business and G-CSF Biosimilar Information
15.4.3 SWOT Analysis of Merck & Co.Sanofi
15.4.4 Merck & Co.Sanofi G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.5 Johnson & Johnson
15.5.1 Company Profile
15.5.2 Main Business and G-CSF Biosimilar Information
15.5.3 SWOT Analysis of Johnson & Johnson
15.5.4 Johnson & Johnson G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.6 Gilead Science
15.6.1 Company Profile
15.6.2 Main Business and G-CSF Biosimilar Information
15.6.3 SWOT Analysis of Gilead Science
15.6.4 Gilead Science G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.7 GlaxoSmithKline
15.7.1 Company Profile
15.7.2 Main Business and G-CSF Biosimilar Information
15.7.3 SWOT Analysis of GlaxoSmithKline
15.7.4 GlaxoSmithKline G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.8 AbbVie
15.8.1 Company Profile
15.8.2 Main Business and G-CSF Biosimilar Information
15.8.3 SWOT Analysis of AbbVie
15.8.4 AbbVie G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.9 Amgen
15.9.1 Company Profile
15.9.2 Main Business and G-CSF Biosimilar Information
15.9.3 SWOT Analysis of Amgen
15.9.4 Amgen G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.10 AstraZeneca
15.10.1 Company Profile
15.10.2 Main Business and G-CSF Biosimilar Information
15.10.3 SWOT Analysis of AstraZeneca
15.10.4 AstraZeneca G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
15.11 Bayer
15.11.1 Company Profile
15.11.2 Main Business and G-CSF Biosimilar Information
15.11.3 SWOT Analysis of Bayer
15.11.4 Bayer G-CSF Biosimilar Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of G-Csf Biosimilar Report
Table Data Sources of G-Csf Biosimilar Report
Table Major Assumptions of G-Csf Biosimilar Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure G-Csf Biosimilar Picture
Table G-Csf Biosimilar Classification
Table G-Csf Biosimilar Applications
Table Drivers of G-Csf Biosimilar Market
Table Restraints of G-Csf Biosimilar Market
Table Opportunities of G-Csf Biosimilar Market
Table Threats of G-Csf Biosimilar Market
Table COVID-19 Impact For G-Csf Biosimilar Market
Table Raw Materials Suppliers
Table Different Production Methods of G-Csf Biosimilar
Table Cost Structure Analysis of G-Csf Biosimilar
Table Key End Users
Table Latest News of G-Csf Biosimilar Market
Table Merger and Acquisition
Table Planned/Future Project of G-Csf Biosimilar Market
Table Policy of G-Csf Biosimilar Market
Table 2019-2029 North America G-Csf Biosimilar Market Size
Figure 2019-2029 North America G-Csf Biosimilar Market Size and CAGR
Table 2019-2029 North America G-Csf Biosimilar Market Size by Application
Table 2019-2024 North America G-Csf Biosimilar Key Players Revenue
Table 2019-2024 North America G-Csf Biosimilar Key Players Market Share
Table 2019-2029 North America G-Csf Biosimilar Market Size by Type
Table 2019-2029 United States G-Csf Biosimilar Market Size
Table 2019-2029 Canada G-Csf Biosimilar Market Size
Table 2019-2029 Mexico G-Csf Biosimilar Market Size
Table 2019-2029 South America G-Csf Biosimilar Market Size
Figure 2019-2029 South America G-Csf Biosimilar Market Size and CAGR
Table 2019-2029 South America G-Csf Biosimilar Market Size by Application
Table 2019-2024 South America G-Csf Biosimilar Key Players Revenue
Table 2019-2024 South America G-Csf Biosimilar Key Players Market Share
Table 2019-2029 South America G-Csf Biosimilar Market Size by Type
Table 2019-2029 Brazil G-Csf Biosimilar Market Size
Table 2019-2029 Argentina G-Csf Biosimilar Market Size
Table 2019-2029 Chile G-Csf Biosimilar Market Size
Table 2019-2029 Peru G-Csf Biosimilar Market Size
Table 2019-2029 Asia & Pacific G-Csf Biosimilar Market Size
Figure 2019-2029 Asia & Pacific G-Csf Biosimilar Market Size and CAGR
Table 2019-2029 Asia & Pacific G-Csf Biosimilar Market Size by Application
Table 2019-2024 Asia & Pacific G-Csf Biosimilar Key Players Revenue
Table 2019-2024 Asia & Pacific G-Csf Biosimilar Key Players Market Share
Table 2019-2029 Asia & Pacific G-Csf Biosimilar Market Size by Type
Table 2019-2029 China G-Csf Biosimilar Market Size
Table 2019-2029 India G-Csf Biosimilar Market Size
Table 2019-2029 Japan G-Csf Biosimilar Market Size
Table 2019-2029 South Korea G-Csf Biosimilar Market Size
Table 2019-2029 Southeast Asia G-Csf Biosimilar Market Size
Table 2019-2029 Australia G-Csf Biosimilar Market Size
Table 2019-2029 Europe G-Csf Biosimilar Market Size
Figure 2019-2029 Europe G-Csf Biosimilar Market Size and CAGR
Table 2019-2029 Europe G-Csf Biosimilar Market Size by Application
Table 2019-2024 Europe G-Csf Biosimilar Key Players Revenue
Table 2019-2024 Europe G-Csf Biosimilar Key Players Market Share
Table 2019-2029 Europe G-Csf Biosimilar Market Size by Type
Table 2019-2029 Germany G-Csf Biosimilar Market Size
Table 2019-2029 France G-Csf Biosimilar Market Size
Table 2019-2029 United Kingdom G-Csf Biosimilar Market Size
Table 2019-2029 Italy G-Csf Biosimilar Market Size
Table 2019-2029 Spain G-Csf Biosimilar Market Size
Table 2019-2029 Belgium G-Csf Biosimilar Market Size
Table 2019-2029 Netherlands G-Csf Biosimilar Market Size
Table 2019-2029 Austria G-Csf Biosimilar Market Size
Table 2019-2029 Poland G-Csf Biosimilar Market Size
Table 2019-2029 Russia G-Csf Biosimilar Market Size
Table 2019-2029 MEA G-Csf Biosimilar Market Size
Figure 2019-2029 MEA G-Csf Biosimilar Market Size and CAGR
Table 2019-2029 MEA G-Csf Biosimilar Market Size by Application
Table 2019-2024 MEA G-Csf Biosimilar Key Players Revenue
Table 2019-2024 MEA G-Csf Biosimilar Key Players Market Share
Table 2019-2029 MEA G-Csf Biosimilar Market Size by Type
Table 2019-2029 Egypt G-Csf Biosimilar Market Size
Table 2019-2029 Israel G-Csf Biosimilar Market Size
Table 2019-2029 South Africa G-Csf Biosimilar Market Size
Table 2019-2029 Gulf Cooperation Council Countries G-Csf Biosimilar Market Size
Table 2019-2029 Turkey G-Csf Biosimilar Market Size
Table 2019-2024 Global G-Csf Biosimilar Market Size by Region
Table 2019-2024 Global G-Csf Biosimilar Market Size Share by Region
Table 2019-2024 Global G-Csf Biosimilar Market Size by Application
Table 2019-2024 Global G-Csf Biosimilar Market Share by Application
Table 2019-2024 Global G-Csf Biosimilar Key Vendors Revenue
Figure 2019-2024 Global G-Csf Biosimilar Market Size and Growth Rate
Table 2019-2024 Global G-Csf Biosimilar Key Vendors Market Share
Table 2019-2024 Global G-Csf Biosimilar Market Size by Type
Table 2019-2024 Global G-Csf Biosimilar Market Share by Type
Table 2024-2029 Global G-Csf Biosimilar Market Size by Region
Table 2024-2029 Global G-Csf Biosimilar Market Size Share by Region
Table 2024-2029 Global G-Csf Biosimilar Market Size by Application
Table 2024-2029 Global G-Csf Biosimilar Market Share by Application
Table 2024-2029 Global G-Csf Biosimilar Key Vendors Revenue
Figure 2024-2029 Global G-Csf Biosimilar Market Size and Growth Rate
Table 2024-2029 Global G-Csf Biosimilar Key Vendors Market Share
Table 2024-2029 Global G-Csf Biosimilar Market Size by Type
Table 2024-2029 G-Csf Biosimilar Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer
  • Novartis
  • Roche
  • Merck & Co.Sanofi
  • Johnson & Johnson
  • Gilead Science
  • GlaxoSmithKline
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Oncology Biosimilars Market Report by Drug Type, Cancer Type, Distribution Channel, and Region 2024-2032 - Product Image

Global Oncology Biosimilars Market Report by Drug Type, Cancer Type, Distribution Channel, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2024 - Product Image

G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Oncology Biosimilars Global Market Report 2024 - Product Image

Oncology Biosimilars Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Oncology Biosimilars Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Oncology Biosimilars Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.